Clinical Evidence Generation

About Spinal Resources

Spinal Resources Inc. is a commercial-stage medical device company specializing in next-generation spinal fusion hardware. Its flagship technology is the Bezier Parametric Curve Rod, an FDA-cleared implant designed to provide a graduated stiffness transition along the spinal construct, aiming to reduce complications like proximal junctional kyphosis (PJK). The company's product portfolio, which also includes the versatile Swedge™ screw system, targets cost-effective, patient-specific care in deformity and degenerative spinal surgery. SRI appears to be in an early commercial growth phase, leveraging recent regulatory clearances and patent protections to capture market share.

About CQ Medical

CQ Medical is a private, commercial-stage medical device company focused on the radiotherapy positioning market. It offers a comprehensive portfolio of hardware and accessory solutions, such as supine breastboards, head & neck immobilization systems, thermoplastics, and couchtops, designed to improve precision, patient comfort, and workflow efficiency in radiation oncology. The company actively invests in clinical research to validate its products and has formed strategic partnerships, like the one with Radiating Hope, to expand global access to cancer care. Its business model is based on selling capital equipment and disposable/ reusable accessories to hospitals and cancer treatment centers worldwide.

About Prytime Medical

Prytime Medical is a commercial-stage medical device company focused on life-saving hemorrhage control. Its core product line centers on REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) catheters, including the ER-REBOA™ PLUS and the newer pREBOA-PRO™, designed for temporary aortic occlusion in trauma and obstetric emergencies. The company has established a global commercial footprint with distribution partners and emphasizes comprehensive clinical training through its REBOA Academy. Prytime operates in a high-stakes, niche segment of the medical device market, addressing a leading cause of potentially survivable death in trauma.

Therapeutic Areas